[1]
2024. Stability of Long-Term Therapeutic Responses to Tralokinumab in Adults with Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine. 8, 4 (Jul. 2024), s412. DOI:https://doi.org/10.25251/skin.8.supp.412.